Can Low Testosterone Affect Heart Health in Men?
- Advanced Medical & Diagnostic Center
- July 12, 2026
- 10 min read
Testosterone Replacement Therapy
Table of Contents
- 1. Why Testosterone Matters Beyond the Bedroom
- 2. The Research on Low Testosterone Heart Health Risks
- 3. How Low Testosterone Affects Cardiovascular Risk Factors
- 4. What the TRAVERSE Trial Revealed About TRT and the Heart
- 5. Signs That Low Testosterone May Be Affecting Your Cardiovascular Health
- 6. How Cardiovascular Risk Markers and Testosterone Are Evaluated Together
- 7. What Men Should Do If They Suspect a Connection
- 8. Frequently Asked Questions
- 9. Taking the Connection Between Hormones and Heart Health Seriously
Most men who research testosterone think about energy, muscle mass, and libido. Few think about their heart. Yet the relationship between low testosterone heart health and cardiovascular risk is one of the most studied areas in men’s hormonal medicine, and the findings are clinically significant for any man whose testosterone levels have dropped below the normal range.
Low testosterone, also known as hypogonadism, does not just affect how a man feels on a day-to-day basis. It affects how his cardiovascular system functions at a metabolic level. The hormonal environment in which the heart and blood vessels operate is directly influenced by circulating testosterone, and when those levels fall, the downstream effects extend well beyond fatigue and reduced drive.
For men who want to understand what testosterone replacement therapy involves and whether it may be appropriate for their situation, the testosterone replacement therapy service page provides a detailed overview of the evaluation and treatment process.
1. Why Testosterone Matters Beyond the Bedroom
Testosterone is classified as an androgen, but its effects on the body extend far beyond reproductive function. It acts on receptors in muscle tissue, bone, the brain, and critically, the cardiovascular system. Cardiac cells contain androgen receptors, and testosterone plays a direct role in regulating vascular tone, red blood cell production, insulin sensitivity, and lipid metabolism.
When testosterone levels are adequate, these systems function within a range that supports cardiovascular health. The hormone helps maintain lean muscle mass, reduces visceral fat accumulation, supports healthy blood glucose regulation, and promotes normal blood pressure by influencing the tone of blood vessel walls.
When levels fall significantly below the clinical threshold of 300 nanograms per deciliter, these regulatory functions begin to deteriorate. The result is not a single identifiable event but a gradual shift in the cardiovascular risk profile that develops over months and years.
2. The Research on Low Testosterone Heart Health Risks
The connection between low testosterone heart health outcomes has been examined in numerous large-scale clinical studies over the past two decades. The overall direction of the evidence points consistently toward an association between testosterone deficiency and increased cardiovascular risk.
According to the NIH, low testosterone levels in men have been associated with an increased risk of developing coronary artery disease, metabolic syndrome, and type 2 diabetes. Reduced testosterone levels in men with congestive heart failure have been shown to correlate with poorer clinical outcomes and increased mortality risk.
Several key findings from the research literature are worth understanding:
- Men with clinically low testosterone have a higher prevalence of coronary artery disease compared to men with normal testosterone levels
- Low testosterone is associated with increased arterial stiffness, which is an independent risk factor for cardiovascular events
- Testosterone deficiency has been linked to increased carotid intima-media thickness, a marker of early atherosclerosis
- Men who undergo androgen deprivation therapy for prostate cancer, which reduces testosterone to near-zero levels, experience significantly elevated rates of diabetes, coronary heart disease, and sudden cardiovascular death
- Multiple long-term studies have found that men with the lowest testosterone levels have higher rates of all-cause and cardiovascular mortality compared to men with normal levels
The research does not establish that low testosterone directly causes heart disease. What it establishes is a consistent and clinically meaningful association between testosterone deficiency and the conditions and markers that increase cardiovascular risk over time.
3. How Low Testosterone Affects Cardiovascular Risk Factors
Understanding the link between low testosterone heart health outcomes requires looking at the specific pathways through which hormonal decline affects the cardiovascular system. Rather than acting on the heart directly, low testosterone primarily increases cardiovascular risk by worsening the metabolic and physiological conditions that drive heart disease.
Visceral Fat Accumulation and Metabolic Syndrome
Low testosterone promotes the accumulation of visceral fat stored deep in the abdominal cavity. Visceral fat drives systemic inflammation, raises triglyceride levels, reduces HDL cholesterol, and promotes insulin resistance. Together these changes constitute metabolic syndrome, one of the strongest modifiable risk factors for cardiovascular disease.
Insulin Resistance and Blood Glucose Dysregulation
Testosterone supports insulin sensitivity in skeletal muscle and other tissues. When levels decline, glucose metabolism becomes less efficient and insulin resistance develops gradually. This increases the risk of type 2 diabetes and contributes to the chronic vascular inflammation that accelerates atherosclerosis over time.
Reduced Lean Muscle Mass and Lower Exercise Capacity
Testosterone is required for maintaining lean muscle mass and supporting aerobic exercise capacity. Men with low testosterone typically experience progressive loss of muscle tissue and reduced stamina. This creates a compounding cycle where reduced activity further worsens metabolic markers and cardiovascular risk.
Blood Pressure and Vascular Function
Testosterone influences the tone of blood vessel walls through its effects on nitric oxide production and vascular smooth muscle. Low testosterone has been associated with elevated blood pressure and reduced arterial elasticity in several clinical studies. Both elevated blood pressure and arterial stiffness are established independent risk factors for heart attack and stroke.
Lipid Profile Changes
The relationship between testosterone and cholesterol is complex but low testosterone is generally associated with less favorable lipid profiles. Men with low testosterone tend to have lower HDL cholesterol and higher LDL cholesterol levels. Both contribute to the progression of coronary artery disease over time.
4. What the TRAVERSE Trial Revealed About TRT and the Heart
For years a critical unanswered question in men’s health was whether testosterone replacement therapy itself increased cardiovascular risk. This concern was significant enough that the FDA mandated in 2015 that manufacturers conduct clinical trials specifically designed to evaluate whether TRT raised the risk of heart attack or stroke.
The TRAVERSE trial was conducted across 316 clinical sites in the United States. It enrolled 5,246 men between the ages of 45 and 80, all of whom had confirmed low testosterone and either preexisting or high risk of cardiovascular disease.
According to the Cleveland Clinic, results showed that testosterone replacement therapy did not result in a higher incidence of major adverse cardiac events, including heart attack, stroke, or cardiovascular death, compared to placebo in this population.
The trial did identify a higher incidence of certain secondary events in the testosterone group, including atrial fibrillation, pulmonary embolism, and acute kidney injury. Researchers have been clear that these findings warrant ongoing attention and that TRT should not be considered universally safe for all men regardless of their clinical profile.
5. Signs That Low Testosterone May Be Affecting Your Cardiovascular Health
The cardiovascular effects of low testosterone are rarely obvious in isolation. Most men do not experience a single defining event that signals a hormonal connection to their heart health. Instead a pattern of symptoms and physical changes develops gradually that, taken together, suggests a hormonal contribution to cardiovascular risk.
Signs worth discussing with a physician include:
- Unexplained weight gain concentrated around the midsection despite no significant change in diet or activity
- Elevated blood pressure readings that have increased over time without a clear dietary or lifestyle explanation
- Declining exercise tolerance and reduced stamina during physical activity that was previously manageable
- Fatigue that persists regardless of sleep quality or duration
- Worsening blood glucose or cholesterol results at routine blood work
- Reduced motivation to stay physically active, which compounds metabolic risk over time
- A combination of low libido, reduced muscle mass, and mood changes occurring alongside the above
No single symptom on this list confirms a hormonal cause. The pattern across multiple symptoms, particularly in men over 40 with no major lifestyle changes, is what raises the clinical question of whether low testosterone is contributing to the overall cardiovascular risk picture.
6. How Cardiovascular Risk Markers and Testosterone Are Evaluated Together
A complete clinical picture of a man’s cardiovascular risk cannot be fully assembled without also understanding his hormonal status. The two are interconnected in ways that make evaluating them separately less informative than looking at them together.
A comprehensive evaluation for men concerned about both testosterone and heart health typically includes early morning blood tests measuring total testosterone and free testosterone alongside SHBG, LH, and FSH. These hormonal markers are assessed alongside a complete metabolic panel that captures fasting glucose, HbA1c, a full lipid profile, and blood pressure readings.
The combined data tells a more complete story than either panel alone. A man with borderline lipid levels and low testosterone, for example, may be experiencing a hormonal contribution to his cardiovascular risk that a lipid panel alone would not reveal. Identifying the hormonal component changes the clinical conversation about what interventions are most appropriate.
For men who want to understand what the testosterone evaluation process looks like from initial testing through treatment and monitoring, the guide on how long testosterone replacement therapy takes to work explains the clinical timeline and what to expect at each stage.
7. What Men Should Do If They Suspect a Connection
The practical response to a suspected connection between hormonal decline and cardiovascular health starts with a clinical evaluation. Laboratory testing is the only way to confirm whether testosterone levels are clinically low, and that confirmation is the necessary foundation for any further clinical conversation about treatment.
Men who receive a confirmed diagnosis of low testosterone and are considering treatment should discuss their full cardiovascular risk profile with their physician before starting. According to the American College of Cardiology, testosterone therapy in men with hypogonadism was not associated with increased overall cardiovascular risk when compared to placebo, but researchers continue to emphasize that proper clinical oversight remains essential throughout treatment.
Monitoring cardiovascular markers throughout TRT is a standard part of responsible management. This includes regular tracking of blood pressure, lipid levels, blood glucose, hematocrit, and PSA to ensure that any changes are identified and addressed promptly throughout the course of treatment.
8. Frequently Asked Questions
The research does not establish direct causation between low testosterone and heart disease. What the evidence consistently shows is a significant association between testosterone deficiency and the metabolic and physiological conditions that drive cardiovascular risk, including visceral fat accumulation, insulin resistance, unfavorable lipid profiles, and arterial stiffness. Whether low testosterone is a cause or a marker of cardiovascular vulnerability remains an active area of research.
The TRAVERSE trial found that TRT did not increase the rate of major adverse cardiac events in men with preexisting or high risk of cardiovascular disease. However, the trial also identified higher rates of atrial fibrillation, blood clots, and kidney problems in the testosterone group.
Men with preexisting heart disease should discuss the full benefit-risk profile of TRT carefully with a physician familiar with both their hormonal and cardiovascular health history before starting treatment.
Some clinical evidence suggests that restoring testosterone to the normal physiological range in men with confirmed hypogonadism can improve cardiovascular risk factors including visceral fat, insulin sensitivity, blood glucose levels, and exercise capacity. These improvements are modest and develop gradually over months of treatment.
TRT is not a cardiovascular treatment and should not be approached as one, but the metabolic improvements associated with hormonal normalization may contribute to a healthier overall cardiovascular risk profile over time.
Men with confirmed low testosterone who also have risk factors for heart disease should discuss a cardiovascular evaluation with their physician. This may include resting electrocardiogram, stress testing, lipid panel, blood pressure monitoring, and blood glucose assessment.
The appropriate combination of tests depends on age, symptom profile, and existing risk factors and should be determined by a physician familiar with the patient’s full medical history.
Most studies examining the association between low testosterone heart health outcomes have used a threshold of approximately 300 nanograms per deciliter as the clinical definition of low testosterone. Some research suggests the association with cardiovascular risk becomes more pronounced at levels below 250 nanograms per deciliter.
The relationship is not strictly linear, and individual factors including age, body composition, and existing health conditions influence how testosterone levels translate into cardiovascular risk for any specific patient.
First responders face occupational conditions including chronic stress, sleep disruption from shift work, and repeated high-adrenaline exposures that are independently associated with both hormonal decline and cardiovascular risk. Men in physically demanding roles experiencing symptoms of low testosterone alongside declining exercise tolerance or worsening cardiovascular risk markers have a clinically meaningful reason to pursue both hormonal and cardiovascular evaluation.
Men in the Hackensack area can find details about what a full testosterone evaluation involves through the testosterone therapy clinic in Hackensack.
9. Taking the Connection Between Hormones and Heart Health Seriously
The evidence connecting low testosterone heart health outcomes is not definitive in the way that the link between smoking and lung cancer is definitive. It is, however, consistent, well-documented, and clinically meaningful enough to warrant attention from any man whose testosterone levels have fallen below the normal range.
The cardiovascular system does not operate in hormonal isolation. Testosterone influences fat distribution, glucose metabolism, vascular tone, and the metabolic conditions that determine long-term heart health in ways that are measurable and clinically significant.
Ignoring the hormonal component of cardiovascular risk means leaving part of the clinical picture unexamined. For men experiencing symptoms of low testosterone alongside changes in their cardiovascular risk markers, the question is not whether the two are connected. The question is whether the connection is being taken seriously enough to prompt a proper evaluation.
Key Takeaways
- Low testosterone is consistently associated with increased cardiovascular risk factors including visceral fat, insulin resistance, arterial stiffness, and unfavorable cholesterol levels
- Testosterone deficiency has been linked to higher rates of coronary artery disease, metabolic syndrome, and cardiovascular mortality in multiple long-term studies
- The TRAVERSE trial found that TRT did not increase major adverse cardiac events in men with confirmed low testosterone and high cardiovascular risk
- The trial also identified higher rates of atrial fibrillation, blood clots, and kidney problems in the TRT group, reinforcing the need for proper clinical oversight
- Low testosterone raises cardiovascular risk primarily through its effects on metabolic health rather than through direct cardiac damage
- A comprehensive evaluation should assess both hormonal and cardiovascular markers together for the most complete clinical picture
- TRT is not a cardiovascular treatment but restoring testosterone to the normal physiological range may support improvements in metabolic markers that contribute to long-term heart health
Understanding Your Hormonal Health Is Part of Understanding Your Heart Health.
The connection between testosterone and cardiovascular function is well documented in the clinical literature. If you have been experiencing symptoms of low testosterone and have questions about what a comprehensive evaluation involves, speaking with a physician who can assess both your hormonal and cardiovascular health gives you the most complete picture of what is happening in your body.
References
- NIH — Testosterone and the Heart. https://pmc.ncbi.nlm.nih.gov/articles/PMC5512682/. Published 2017.
- Cleveland Clinic — TRAVERSE Trial: TRT and Cardiac Events. https://newsroom.clevelandclinic.org/2023/06/16/cleveland-clinic-led-trial-finds-testosterone-replacement-therapy-does-not-increase-incidence-of-major-adverse-cardiac-events-for-men-with-low-testosterone. Published June 2023.
- American College of Cardiology — Cardiovascular Safety of Testosterone Replacement Therapy. https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2023/06/20/14/42/cardiovascular-safety-of-testosterone. Published June 2023.
